Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?

por Müllhaupt, Beat, Bruggmann, Philip, Bihl, Florian, Blach, Sarah, Lavanchy, Daniel, Razavi, Homie, Robbins Scott, Sarah, Semela, David, Negro, Francesco
Publicado 2018

The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries

por Mennini, Francesco S., Marcellusi, Andrea, Robbins Scott, Sarah, Montilla, Simona, Craxi, Antonio, Buti, Maria, Gheorghe, Liana, Ryder, Stephen, Kondili, Loreta A.
Publicado 2021

A micro-elimination approach to addressing hepatitis C in Turkey

por Idilman, Ramazan, Razavi, Homie, Robbins-Scott, Sarah, Akarca, Ulus Salih, Örmeci, Necati, Kaymakoglu, Sabahattin, Aygen, Bilgehan, Tozun, Nurdan, Güner, Rahmet, Bodur, Hurrem, Lazarus, Jeffrey V.
Publicado 2020